Lymphoma, Intermediate-Grade

Known as: Intermediate-Grade Lymphomas, Lymphoma, Intermediate Grade, Lymphomas, Intermediate-Grade 
A type of lymphoma that grows and spreads quickly and has severe symptoms. Also called aggressive lymphoma and high-grade lymphoma.

Topic mentions per year

Topic mentions per year

1984-2014
0246819842014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
PURPOSE To assess the outcome of high-dose therapy with autologous stem-cell support in patients with histologic transformation… (More)
Is this relevant?
1999
1999
We analyzed a group of 51 patients with primary refractory and relapsed intermediate-grade lymphoma (IGL) from the time of… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE To investigate the use of a nonmyeloablative fludarabine-based preparative regimen to produce sufficient… (More)
Is this relevant?
1997
1997
In order to determine the activity of paclitaxel in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL), we… (More)
Is this relevant?
1997
1997
Based on preclinical studies demonstrating synergy between gallium and hydroxyurea, we evaluated the efficacy and toxicity of… (More)
Is this relevant?
1996
1996
PURPOSE To evaluate outcomes and identify prognostic factors in allogeneic bone marrow transplantation in patients with end-stage… (More)
Is this relevant?
1995
1995
PURPOSE To determine whether modifying the standard regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP… (More)
Is this relevant?
1994
1994
PURPOSE To evaluate the benefit of anthracycline-based chemotherapy, identify prognostic factors, and determine the value of the… (More)
Is this relevant?
1989
1989
Evolution of low-grade Non-Hodgkin Lymphoma (NHL) into a more aggressive neoplasm is a common, well-documented event in NHL. The… (More)
Is this relevant?
1984
1984
We report the results of a trial of recombinant leukocyte A interferon in previously treated patients with non-Hodgkin's lymphoma… (More)
Is this relevant?